IC
OGN icon

Inscription Capital’s Organon & Co OGN Stock Holding History

Inscription Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,828
Closed -$467K – 236
2022
Q2 		$467K Buy
+13,828
New +$484K 0.08% 161
2021
Q3 		– Sell
-7,195
Closed -$218K – 348
2021
Q2 		$218K Buy
+7,195
New +$237K 0.02% 297

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Inscription Capital's OGN Position: Q3 2022 in Review

Inscription Capital sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 13,828 shares — an estimated $467K sold.

Inscription Capital first reported a position in OGN in Q2 2021 and held it in 2 quarters. The position peaked at $467K in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Inscription Capital reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Inscription Capital sold 13,828 Organon & Co shares in Q3 2022, an estimated $467K.
  • Inscription Capital first reported a position in Organon & Co in Q2 2021 and held it in 2 quarters.
  • Inscription Capital's Organon & Co position peaked at $467K in Q2 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Inscription Capital's 13F filing for Q3 2022, filed 14 Nov 2022.